Stocks Comparison
Baxter International vs Resmed: revenue, profit, margins and growth compared
Baxter International brought in $11.2B of revenue in fiscal 2025, Resmed $5.7B in fiscal 2026. Revenue changed by +5.7% at Baxter International and +9.9% at Resmed on the year before, so Resmed grew faster. Baxter International kept -8.5% of its revenue as net profit, Resmed 26.9%. Free cash flow was $332M at Baxter International and $1.6B at Resmed.
Side by side, latest fiscal year
| BAX | RMD | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2026 (June 30, 2026) |
| Revenue | $11.2B | $5.7B |
| Revenue growth | +5.7% | +9.9% |
| Net income | -$957M | $1.5B |
| Net margin | -8.5% | 26.9% |
| Free cash flow | $332M | $1.6B |
| Free cash flow margin | 3.0% | 29.2% |
| Earnings per share (diluted) | -$1.87 | $10.43 |
| Cash | $2B | $1.5B |
| Debt | $9.4B | $399.4M |
| Price to earnings | n/a | 24.2 |
| Market value | $13.3B | $36.4B |
| Dividend yield | 2.03% | 0.95% |
| Rank by revenue in sector | #44 of 751 · Health care | #61 of 751 · Health care |
Over the years
Questions about Baxter International and Resmed
Which is bigger by revenue, Baxter International or Resmed?
Baxter International is bigger by revenue: $11.2B in fiscal 2025, against $5.7B for Resmed in fiscal 2026.
Which keeps more of its revenue as profit, Baxter International or Resmed?
Baxter International had a net margin of -8.5% in fiscal 2025; Resmed had 26.9% in fiscal 2026.
Which grew revenue faster, Baxter International or Resmed?
In their latest fiscal years revenue changed by +5.7% at Baxter International and +9.9% at Resmed.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.